Interaction with blood components plays a crucial role in asialoglycoprotein receptor-mediated in vivo gene transfer by galactosylated lipoplex

被引:27
作者
Fumoto, S [1 ]
Kawakami, S [1 ]
Shigeta, K [1 ]
Higuchi, Y [1 ]
Yamashita, F [1 ]
Hashida, M [1 ]
机构
[1] Kyoto Univ, Dept Drug Delivery Res, Grad Sch Pharmaceut Sci, Sakyo Ku, Kyoto 6068501, Japan
关键词
D O I
10.1124/jpet.105.089516
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
In this study, we evaluated the effect of blood components (whole blood and serum) on asialoglycoprotein receptor-mediated in vivo gene transfer. The hepatic transfection activity of galactosylated lipoplex preincubated with serum was approximately 10 times higher than that without incubation after intraportal injection in mice. However, preincubation with whole blood significantly reduced hepatic transfection activity. Fluorescent resonance energy transfer analysis and agarose gel electrophoresis revealed that preincubation with serum reduced the degree of destabilization of the galactosylated lipoplex in blood, partially supporting enhanced hepatic transfection activity by preincubation with serum. Inhibition of hepatic transfection activity by predosing galactosylated bovine serum albumin indicated that the galactosylated lipoplex exposed to serum is recognized by asialoglycoprotein-receptors on hepatocytes. Inactivation of serum prior to mixing with galactosylated lipoplex reduced liver accumulation and completely abolished enhancement of hepatic transfection activity by preincubation with active serum, suggesting that not only the stability of the lipoplex in blood but also the serum opsonin activity plays important roles. Alternatively, preincubation with inactivated serum reduced the lung accumulation and inflammatory cytokine production of galactosylated lipoplex. The information provided by this study will be valuable for the future use, design, and development of galactosylated lipoplex for in vivo asialoglycoprotein receptor-mediated gene transfer.
引用
收藏
页码:484 / 493
页数:10
相关论文
共 38 条
[1]   Effects of complement depletion on the pharmacokinetics and gene delivery mediated by cationic lipid DNA complexes [J].
Barron, LG ;
Meyer, KB ;
Szoka, FC .
HUMAN GENE THERAPY, 1998, 9 (03) :315-323
[2]  
CHONN A, 1992, J BIOL CHEM, V267, P18759
[3]   Biophysical characterization of cationic lipid:DNA complexes [J].
Eastman, SJ ;
Siegel, C ;
Tousignant, J ;
Smith, AE ;
Cheng, SH ;
Scheule, RK .
BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES, 1997, 1325 (01) :41-62
[4]   Lipoplex-induced hemagglutination: potential involvement in intravenous gene delivery [J].
Eliyahu, H ;
Servel, N ;
Domb, AJ ;
Barenholz, Y .
GENE THERAPY, 2002, 9 (13) :850-858
[5]   Enhanced hepatocyte-selective in vivo gene expression by stabilized galactosylated liposome/plasmid DNA complex using sodium chloride for complex formation [J].
Fumoto, S ;
Kawakami, S ;
Ito, Y ;
Shigeta, K ;
Yamashita, F ;
Hashida, M .
MOLECULAR THERAPY, 2004, 10 (04) :719-729
[6]   Analysis of hepatic disposition of galactosylated cationic liposome/plasmid DNA complexes in perfused rat liver [J].
Fumoto, S ;
Nakadori, F ;
Kawakami, S ;
Nishikawa, M ;
Yamashita, F ;
Hashida, M .
PHARMACEUTICAL RESEARCH, 2003, 20 (09) :1452-1459
[7]  
Fumoto Shintaro, 2003, Drug Metab Pharmacokinet, V18, P230, DOI 10.2133/dmpk.18.230
[8]  
Gatmaitan Z, 1996, AM J PATHOL, V148, P2027
[9]  
HAMURO J, 1978, Journal of Immunology, V120, P438
[10]  
Harvie P, 2000, J PHARM SCI, V89, P652, DOI 10.1002/(SICI)1520-6017(200005)89:5<652::AID-JPS11>3.0.CO